MARKET WIREYahoo! Finance Canada • 14h ago
Core Laboratories Inc. (CLB) Stock Price, News, Quote & HistoryYahoo! Finance Canada report covering Core Laboratories Inc. (CLB) market action, institutional positioning, and fundamental catalysts.
Why CLB Stock surged +2.31% Today — RQD Quant Desk Flash
$10.64 +2.31% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $10.66
Core Laboratories Inc. (CLB) carries a Roarable Rating of D+ (Sell) with 58/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D+ • SELL / AVOID
Cap $477.2M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on CLB Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is CLB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, Core Laboratories Inc. (NYSE: CLB) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 58/100 at a spot price of $10.64 (+2.31% 1D, market cap $477.2M). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 16/20. Across 211 tracked Energy issuers, CLB ranks #106 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does CLB compare to NGS and RNGR in the Energy sector?
▼
Within the Energy sector (Oilfield Services/Equipment), CLB carries a Roarable D+ (58/100 RQD), trailing P/E of 16.1x, gross margin of 20.7%, and ROIC of 12.6%. By comparison, NGS (Natural Gas Services Group Inc.) holds a E grade (33/100 RQD, P/E 21.3x, ROIC 10.7%, cap $424.1M) and RNGR (Ranger Energy Services Inc. (Class A)) posts a D+ grade (53/100 RQD, P/E 29.4x, ROIC 4.2%, cap $361.3M). Among the 5-stock peer group, CLB leads on earnings multiple (16.1x) while CLB leads on capital efficiency (12.6% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for CLB?
▼
Per CLB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001958086), Core Laboratories Inc. generated $526.5M in revenue (+0.5% YoY), $29.7M in net income, and $25.8M in free cash flow against $584.0M in total assets and $110.3M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $10.66 (+0.23%)🧬 Cannibal Buyback (-2.36% YoY Shares)⚙️ Cash Engine: 13/20 (C) • 4.9% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 58/100 (D+) historically posted market-perform odds over rolling 90-day windows (+0.0% avg 90D alpha vs SPY • 52.7% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →RQD QUANT TACHOMETERSELL / AVOID • D+
JEV AI Jury Split (Battleground)
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D+ · Rk C-
Each axis scored 0–20
12M PRICE TARGET CONE+0% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CLB)Realized 20D OHLCV Swing Band: ±8.3%
Deterministic 5-Pillar Attribution (58/100 Composite)
🔍 WHY CLB SCORES 58/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Insider Conviction & Share Dilution+16/20 pts (28% of score)
SEC Form 4 / 13F Thermometer: 80% Net Buy • Cannibal Buyback (-2.36% YoY Shares)
▲ #2 Bullish Driver: Cash Engine Quality+13/20 pts (22% of score)
SEC XBRL FY 2025 (10-K): 4.9% FCF Margin ($25.8M FCF) & 20.7% Gross Margin
▼ #1 Drag / Risk Factor: Whale & Options Positioning5/20 pts (-15 pt drag)
Put hedging (50% put share) caps near-term gamma upside (-15 pts vs max)
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade C-$10.01+1.4% Next Q
50
Q2 (-2Q)Grade C-$10.15+0.7% Next Q
53
Q3 (-1Q)Grade C$10.22+4.1% Next Q
55
CurrentGrade D+$10.64+0% Hist 90D α
58
Trajectory: C- (50) → D+ (58)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the CLB Bull Thesis Could Fail
Even with a 58/100 (D+) score, CLB faces multiple-compression risk if 16.1x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Broader market pullbacks can still drag down strong stocks in the short run.
⚠️ Forensic Kill-Switch #2
Dilution & Margin Drag: Cannibal Buyback (-2.36% YoY Shares) — any gross margin slip below 18.2% triggers an automatic RQD downgrade.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($10.95) or 200D SMA ($13.82) invalidates the momentum regime and cuts Target Base ($10.64) toward Bear Floor ($8.30).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $CLB• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “CLB Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why CLB Stock surged +2.31% Today — RQD Quant Desk Flash
Core Laboratories Inc. (CLB) surged +2.31% to $10.64, trading at 13% of its 52-week range ($9.13 – $20.36). Stretched risk/reward at 16x P/E (13% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 13% of its 52-week range ($9.13 – $20.36) with RSI-14 at 50.5 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±8.3% around $10.64 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D+ (Sell) backed by 20.7% gross margin and $25.8M annual free cash flow.
Live CLB Headlines & Catalysts
MARKET WIRESimply Wall St • 17h ago
Core Laboratories (NYSE:CLB) - Stock AnalysisSimply Wall St report covering Core Laboratories Inc. (CLB) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo Finance • 20h ago
Core Laboratories (CLB) Stock Price Shrugs At Q3 Results As Margins TightenYahoo Finance report covering Core Laboratories Inc. (CLB) market action, institutional positioning, and fundamental catalysts.
MARKET WIRETradingView • 23h ago
Core Laboratories (NYSE:CLB) reports Q3 2026 in line with expectationsTradingView report covering Core Laboratories Inc. (CLB) market action, institutional positioning, and fundamental catalysts.
MARKET WIREGuruFocus • 1d ago
Core Laboratories (CLB) Declares Quarterly Dividend of $0.01, YiGuruFocus report covering Core Laboratories Inc. (CLB) market action, institutional positioning, and fundamental catalysts.
RISK WATCHMarketBeat • 1d ago
Core Laboratories Inc. $CLB Stock: CWA Asset Management Group LLC Cuts HoldingsMarketBeat report covering Core Laboratories Inc. (CLB) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo Finance • 1d ago
What Core Laboratories Holders Got Wrong Before The SlideYahoo Finance report covering Core Laboratories Inc. (CLB) market action, institutional positioning, and fundamental catalysts.
MARKET WIREGuruFocus • 1d ago
Core Laboratories (CLB) Set to Report Q3 Earnings on October 28GuruFocus report covering Core Laboratories Inc. (CLB) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo • 2d ago
The most interesting analyst questions from Core Laboratories’s Q3 earnings callCore Laboratories faced continued headwinds in Q3 2026, with revenue declining year over year and operating margins pressured by persistent geopolitical conflicts in the Middle East and Eastern Europe. Management attribu
MARKET WIREYahoo • 3d ago
Core Laboratories Q3 Earnings Call HighlightsCore Laboratories (NYSE:CLB) reported higher third-quarter revenue, operating income and earnings per share from the prior quarter, while geopolitical disruptions in the Middle East and Russia-Ukraine continued to constr
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring CLB)
- ✓Walkthrough of CLB's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
CLB // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -22.79%▼ DESCENDING CHANNEL
2026-11-02O $10.49H $10.64L $10.40C $10.64VOL 1.04M
RES: $12.01SUP: $9.05SMA50: $10.95SMA200: $13.82
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
CLB Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.7%/yr Implied 5Y Growth
vs. +0.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on CLB today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for CLB. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for CLB today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CLB)
Energy Rank #106 of 211
⚔️ NGS vs CLB Full Matrix →
1. Head-to-Head Energy Peer Comparison (CLB vs. NGS, RNGR, NOA, ACDC)
Industry: Oilfield Services/Equipment (20 Tracked Issuers)Across 211 tracked Energy securities in the Roarable RQD universe, Core Laboratories Inc. (CLB) ranks #106 by composite RQD confidence (58/100, grade D+) and #154 by equity capitalization ($477.2M). Within this direct 5-issuer industry benchmark cohort, CLB leads on earnings valuation at 16.1x trailing P/E, while CLB leads on capital efficiency and profitability with 12.6% ROIC and 20.7% gross margin. CLB currently leads its immediate peer cohort in composite quantitative strength at 58/100 (D+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| CLB
ACTIVE
Core Laboratories Inc. | D+ | 58/100 | 16.1x | 20.7% | 12.6% | +2.31% | $477.2M | Benchmark Subject |
| NGS Natural Gas Services Group Inc. | E | 33/100 | 21.3x | — | 10.7% | -1.46% | $424.1M | /ngs-vs-clb → |
| RNGR Ranger Energy Services Inc. (Class A) | D+ | 53/100 | 29.4x | — | 4.2% | -1.44% | $361.3M | /rngr-vs-clb → |
| NOA North American Construction Group Ltd. (no par) | D | 49/100 | — | — | — | -4.39% | $347.5M | /noa-vs-clb → |
| ACDC ProFrac Holding Corp. (Class A) | E | 33/100 | — | — | -11.4% | +0.62% | $883.3M | /acdc-vs-clb → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001958086In its most recent audited fiscal period (FY2025, filed 2025-12-31), Core Laboratories Inc. (CLB) reported GAAP revenue of $526.5M (+0.5% vs. FY2024 revenue of $523.8M , and +3.3% cumulative change since FY2023) , GAAP net income of $29.7M, operating cash flow of $37.0M, and free cash flow of $25.8M (-42.0% YoY). On the balance sheet, CLB closed FY2025 with $584.0M in total assets against $110.3M in total debt (Altman Z-Score: N/A, Piotroski F-Score: 6/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $526.5M | $29.7M | $37.0M | $25.8M | $584.0M | $110.3M |
| FY2024 (FY) | 2024-12-31 | $523.8M | $31.4M | $56.4M | $44.5M | $585.1M | $126.1M |
| FY2023 (FY) | 2023-12-31 | $509.8M | $36.7M | $24.8M | $24.8M | — | — |
3. CLB Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs CLB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, Core Laboratories Inc. (NYSE: CLB) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 58/100 at a spot price of $10.64 (+2.31% 1D, market cap $477.2M). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 16/20. Across 211 tracked Energy issuers, CLB ranks #106 in composite RQD confidence.
How does CLB compare to NGS and RNGR in the Energy sector?
Within the Energy sector (Oilfield Services/Equipment), CLB carries a Roarable D+ (58/100 RQD), trailing P/E of 16.1x, gross margin of 20.7%, and ROIC of 12.6%. By comparison, NGS (Natural Gas Services Group Inc.) holds a E grade (33/100 RQD, P/E 21.3x, ROIC 10.7%, cap $424.1M) and RNGR (Ranger Energy Services Inc. (Class A)) posts a D+ grade (53/100 RQD, P/E 29.4x, ROIC 4.2%, cap $361.3M). Among the 5-stock peer group, CLB leads on earnings multiple (16.1x) while CLB leads on capital efficiency (12.6% ROIC).
What are the biggest fundamental strengths and SEC risk factors for CLB?
Per CLB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001958086), Core Laboratories Inc. generated $526.5M in revenue (+0.5% YoY), $29.7M in net income, and $25.8M in free cash flow against $584.0M in total assets and $110.3M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is CLB trading relative to its 50-day, 200-day, and 52-week technical levels?
CLB last traded at $10.64 (+2.31% on volume of 880,196 shares), positioning the stock -2.83% below its 50-day simple moving average ($10.95) and -23.01% below its 200-day simple moving average ($13.82). Across its 52-week range of $9.13 to $20.36, CLB sits at the 13.4% percentile with a 14-day RSI of 50.5 (NEUTRAL RANGE) and an implied next-earnings move of ±8.3% ($9.76 to $11.52).
CLB Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is CLB stock moving today?
Why CLB Stock surged +2.31% Today — RQD Quant Desk Flash. Stretched risk/reward at 16x P/E (13% return on capital) under elevated 10-year interest-rate pressure.
ROARABLE RATING BRIEF • RQD 58/100 (D+)
✓ STAGE-C NUMBER FIREWALL VERIFIED
CLB — Core Laboratories Inc.: What the Facts Mean to a Prospective Investor
Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:36:02Z
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, CLB scores 58 out of 100, grading D+ with the verdict "Roarable Sell — Weak Fundamentals / Trim." The five pillars are: Fundamental Cash Engine 13/20 (ROIC 12.6%; FCF yield 5.41%), Whale 13F Flow 5/20 (institutional accumulation and options positioning), Insider Conviction 16/20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit 11/20 (Beta 1.0; sector sensitivity), and Forensic Balance Sheet 13/20 (Altman Z 2.5; Piotroski F 6/9; Debt/Equity 0.41). For a prospective investor, the strongest pillar is insider conviction, which is the highest-scoring element, while institutional flow is the weakest at 5/20, signaling limited institutional accumulation in the source data. The cash-generation and balance-sheet pillars sit at mid-range scores, suggesting the business produces cash and carries moderate leverage without showing a clear margin of safety. The rating's overall tilt is negative, so the upside case rests mainly on insider signaling and any valuation re-rating, while the downside case reflects weak institutional support and a sector-sensitive, beta-1.0 profile. Valuation tradeoffs are visible in the multiples: a P/E (TTM) of 16.1 and EV/EBITDA of 8.6 are not distressed-level figures, yet the price sits near the lower part of its 52-week range, so investors weighing entry should consider whether the discount reflects fundamentals or sentiment.
Snapshot
Financial Trend
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $526.5M | $56.5M | $29.7M | N/A | $25.8M | $22.7M | $110.3M |
| FY 2024 | $523.8M | $58.6M | $31.4M | N/A | $44.5M | $19.2M | $126.1M |
| FY 2023 | $509.8M | $54.6M | $36.7M | N/A | $24.8M | N/A | N/A |
Per the market data, gross margin is 20.7%, operating margin 10.7%, and net margin 5.6%, with ROIC of 12.6%. Per the Roarable RQD rating, the Altman Z-Score is 2.5, the Piotroski F-Score is 6/9, and Debt/Equity is 0.41. Reported net income declined from $36.7M (FY 2023) to $31.4M (FY 2024) to $29.7M (FY 2025), while revenue rose modestly across the three periods. Debt declined from $126.1M to $110.3M over FY 2024–FY 2025, and cash increased from $19.2M to $22.7M.
Recent Catalysts & News Wire Analysis
Per the recent news and catalysts feed, the most recent items are: a Yahoo! Finance Canada market report (YELLOW, Market Wire), a Simply Wall St stock analysis (YELLOW, Market Wire), a Yahoo Finance report headlined around Q3 results and tightening margins (YELLOW, Market Wire), a TradingView report stating Q3 2026 results were in line with expectations (YELLOW, Market Wire), a GuruFocus item on a quarterly dividend of $0.01 (YELLOW, Market Wire), and a MarketBeat item reporting that a holder cut positions (RED, Risk Watch). The only RED-flagged item is the holdings-reduction report, which is the primary risk-watch signal in the feed. The margin-tightening headline is a second cautionary theme, while the in-line Q3 report and the dividend declaration are neutral-to-supportive. Per the Butterfly Supply-Chain Graph, no proprietary signals or supply-chain links are recorded for this issuer.
Open Questions
- What specific products and end-markets drive CLB revenue, and how concentrated is its customer base?
- What is the reported EPS for FY 2024 and FY 2025, given that the financial data lists EPS as N/A for these periods?
- What drove the margin tightening referenced in the Q3 results headline, and is it expected to persist?
- What are the cash and debt balances for FY 2023, which are listed as N/A in the financial data?
- Which institutional holders increased or decreased positions, and what is the composition of insider and Congressional trading behind the insider-conviction pillar?
CLB Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Core Laboratories Inc. (CLB) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Yahoo! Finance Canada • 14h ago
Core Laboratories Inc. (CLB) Stock Price, News, Quote & History Yahoo! Finance Canada report covering Core Laboratories Inc. (CLB) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Simply Wall St • 17h ago
Core Laboratories (NYSE:CLB) - Stock Analysis Simply Wall St report covering Core Laboratories Inc. (CLB) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance • 20h ago
Core Laboratories (CLB) Stock Price Shrugs At Q3 Results As Margins Tighten Yahoo Finance report covering Core Laboratories Inc. (CLB) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingView • 23h ago
Core Laboratories (NYSE:CLB) reports Q3 2026 in line with expectations TradingView report covering Core Laboratories Inc. (CLB) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE GuruFocus • 1d ago
Core Laboratories (CLB) Declares Quarterly Dividend of $0.01, Yi GuruFocus report covering Core Laboratories Inc. (CLB) market action, institutional positioning, and fundamental catalysts.
🔴 RISK WATCH MarketBeat • 1d ago
Core Laboratories Inc. $CLB Stock: CWA Asset Management Group LLC Cuts Holdings MarketBeat report covering Core Laboratories Inc. (CLB) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance • 1d ago
What Core Laboratories Holders Got Wrong Before The Slide Yahoo Finance report covering Core Laboratories Inc. (CLB) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE GuruFocus • 1d ago
Core Laboratories (CLB) Set to Report Q3 Earnings on October 28 GuruFocus report covering Core Laboratories Inc. (CLB) market action, institutional positioning, and fundamental catalysts.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
CLB Bull vs. Bear Conversation Board — What's Your Call at $10.64?
🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON CLB 🐻 50% BEARISH CONVICTION
RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST
🎯 Target: $11.23 (+8.0%)
📌 Pinned Debate 🔥 Official Bull vs. Bear Debate: Is CLB (D+ • RQD 58/100) a Buy at $10.40?
Welcome to the CLB (Core Laboratories Inc.) Roar Pit. Current RQD Composite is 58/100 (Roarable Sell — Weak Fundamentals / Trim) in Oilfield Services/Equipment. Bulls point to capital efficiency (12.6% ROIC), while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
RE RedlineAuditor Forensic Accounting Watch 🐻 BEARISH
🎯 Target: $7.80 (-25.0%)
Spot @ $10.40 Pump the brakes on CLB — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on CLB, but look at what you are paying: 16.1x trailing P/E with 20.7% gross margins. Unless Core Laboratories Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
TA TapeReader_Pro Verified K Arena Trader 🐂 BULLISH
🎯 Target: $13.31 (+28.0%)
Spot @ $10.40 CLB cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on CLB, the market is fixating on short-term headline noise in Oilfield Services/Equipment and ignoring the balance sheet and cash flow trajectory. At $10.40 (52-wk range $9.13 - $20.36), any beat on forward guidance forces shorts and underweight funds to chase.